October to December 2007

Agilent Technologies Announces Biggest Sale in India to Date: More than 50 Liquid Chromatography, Nine Gas Chromatography Systems

Ablynx extends agreement with Wyeth

Olympus digital microscope camera range offers flexibility for any application

Syngene New GeneSnap Image Acquisition Software Promises Reproducible - Gel Imaging in Seconds

New time for Cyclacel conference call for update on Sapacitabine Phase II plans

Santaris Pharma raises €20 million of new equity

Ablynx reports positive Phase I results for its anti-thrombotic NanobodyR, ALX-0081

Biopartners terminates collaboration with The Medical House

PepTcell and Gador Announce Collaboration to Develop Novel Vaccine for "Neglected" Chagas disease

Simcyp - Virtual trials could improve drug development

OrphaMed selects IDBS' fully integrated data management system

10th Annual Customer Experience Conference: Using Quality to Improve the Customer Experience

Equinox launches world’s first pay per use service (PPU) for bioinformatics software

OXFORD BIOMEDICA INITIATES PHASE I/II TRIAL OF PROSAVIN GENE-BASED TREATMENT FOR PARKINSON'S DISEASE

Cyclacel Pharmaceuticals to host conference call on upcoming Sapacitabine Phase II trials

Forbion Capital Partners leads EUR30M Series B Financing in Fovea Pharmaceuticals S.A

Dyversity 2D Gel Image Analyser used at Major UK University To Help Accurately Detect Proteins Associated with Stem Cell Differentiation

Protagen and Tomy Digital Biology announce distribution agreement for Modiro™ in Japan

ABLYNX ANNOUNCES EXTENSION OF NANOBODY® DRUG DISCOVERY AND DEVELOPMENT ALLIANCE

Magnisense Appoints Hayat El Yousfi Marketing and Clinical Trials Manager

OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX® PHASE III TRIAL IN RENAL CANCER

CYCLACEL REPORTS UPDATED PHASE I SAPACITABINE DATA

Genentech - Roche: FDA may still approve Avastin despite setback

New strategy to reduce multiple births & complications after fertility treatment

Accelrys and Agilent Technologies Enter Into Comprehensive Resale Agreement

Agilent Technologies and BioNanomatrix to Develop Genetic Analysis System Using Nanoscale Whole Genome Imaging Technology

Agilent Technologies Integrates ICP-MS with Enterprise Content Management System for Regulated Pharma Applications

Agilent Technologies Signs Agreement to Acquire Velocity11, a Leader in Life Science Lab Automation and Robotics

Pharmaceutical Profiles maintains GMP certification

Lisuride sc infusion therapy has proved highly effective in reducing severe motor complications in patients with advanced Parkinson’s Disease (PD) refractory to optimized oral therapy.

OXFORD BIOMEDICA WINS SCRIP’S LICENSING DEAL OF THE YEAR AWARD

M&A IS TRANSFORMING THE BIOTECH LANDSCAPE, SAYS INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Cyclacel Pharmaceuticals to present Sapacitabine Phase I data at US American Society of Hematology conference

Qualyst and Solvo Biotechnology announce alliance for B CLEAR® in Europe

BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer

HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders

Icelandic Biotech Company Introduces First-ever Biorisk-free Growth Factors to Global R&D Market

THE WORLD ECONOMIC FORUM ANNOUNCES TECHNOLOGY PIONEERS 2008: OXITEC SELECTED

Senior appointments further strengthen Pharmaceutical Profiles scientific expertise

Immutep Announces Positive Interim Results From a Study of Immufact(R) IMP321 in Metastatic Breast Cancer

OXFORD BIOMEDICA WINS TECHMARK AWARD

EU-US authorities to harmonize medicines approval process

CLINTEC INTERNATIONAL TO LOCATE GLOBAL HEADQUARTERS IN SCOTLAND CREATING UP TO 240 NEW JOBS

NextGen Sciences Announces Collaboration with the Harvard Institute of Proteomics

Brane Discovery commences Phase I trial of BND-11624 for neuropathic and osteoarthritic pain

Cyclacel Pharmaceuticals announces pipeline update

Cytheris appoints Richard Keatinge as Chief Business Officer

Next Generation Multi-application Imaging and Analysis System Perfectly Combines Accuracy with Versatility

Q Chip's ReaXT Assays speed up bacterial identification

Biota (ASX:BTA) announces LANI Phase II trial commencement

Northbank Communications Strengthens Team with Four PromotionsNorthbank Communications Announces Appointment of New Account Executive

Northbank Communications Strengthens Team with Four Promotions

SOLVO Biotechnology among the region’s fastest growing

SANTEN BEGINS CLINICAL TRIALS WITH OAKWOOD-MANUFACTURED PRODUCT

OXFORD BIOTECH INVESTMENT BUOYANT DESPITE MARKET TURBULENCE

Bionest Partners Outlines Winning Pathways for BioPharma Companies in Oncology

Agilent & BioTrove Collaborate for Ultra-High-Throughput Mass Spectrometry Solution

InferMed appoints new Director of Product Development to Executive Team

DBV TECHNOLOGIES STENGTHENS BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD

BAC launches CaptureSelect toolbox for antibody purification

SOLVO Biotechnology (Hungary) and KRISHGEN BioSystems (India) announce Distribution and Service Representation Agreement for SOLVO’s Membrane Transporter Assay Products and Services in India, Singapore, Malaysia, Hong Kong, Thailand, Srilanka, Bangladesh

NextGen Sciences Appoints New CEO and Expands Service Offering to Include Protein Biomarker Monitoring

Molecular Partners Appoints Jörn Aldag as Chariman of the Board

Santaris Pharma's HIF-1 alpha antagonist begins second phase 1 study against solid tumours and lymphoma

BioInvent and ThromboGenics Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell

Pharmaceutical Profiles study shaves months and millions off drug development program

National Heart and Lung Institute Uses G:BOX Chemi HR16 Imager To Help Identify Proteins Associated with Heart Disease

Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS

Magnisense Will Give Talk at MMM'52

OXFORD BIOMEDICA AND SIGMA-ALDRICH WIN KEY RULING IN OPEN BIOYSTEMS PATENT INFRINGEMENT DISPUTE

Biota (ASX:BTA) announces Relenza royalties of AU$4.5M

Cobra Biomanufacturing to Support Development of the University of Rochester's HIV Vaccine Platform

Ipsat Therapies Announces Positive Top-line Data from Phase IIb Study of Ipsat P1A

IDBS announces the release of E-WorkBook Suite 7.1

Diatos announces successful completion of Phase I trial for DTS-201, a novel doxorubicin prodrug

Promega introduces new HaloCHIPT System

Q Chip Introduces ReaX™ Assays Range

Cobra Signs Agreement with Advaxis to Manufacture Lovaxin C Vaccine

Borean Pharma receives Notice of Allowance of HIV drug patent by U.S. Patent & Trademark Office

POLYPURE INTRODUCES KEY MONODISPERSED PEG COMPOUND

RICERCA BIOSCIENCES, LLC APPOINTS DR. JAMES R. SZABO Vice President–biology services

BioInvent Interim Report 1 January – 30 September 2007

Diatos Announces Start of the Preclinical Toxicology Program of DTS-108, a second generation irinotecan

Auto-Montage Pro Software Used at Respected UK Teaching Hospital To Confirm Diagnosis of a Parasitic Disease Unusual to the UK

Spain prevents automatic substitution of biological medicines, providing clarity for pharmacists and patients

Pharmaceutical Profiles to share unique expertise

Lab21 Announces Licence Agreement with Ark Therapeutics for Predictive Coronary Heart Disease Diagnostic

Ablynx announces intention to launch an Initial Public Offering (IPO) on Eurolist by Euronext Brussels

Automated Colony Counter Generates Accurate OPKA Assay Results

ClinTec International expands their full-service capabilities in Germany

Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication

Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health

OEM Contract Manufacturing to Grow $11 Billion by 2011

Advancements in Population Age and Technology

DNA Sequencing Equipment Market to Fragment and

Worldwide Skin-Ulcer Treatment Market to See New Growth,

Efforts to Improve Efficiency of Drug Discovery Expected to Grow

World Physician Office Lab Point-of-Care Diagnostics Market to Reach $2.4 Billion by 2011

Imports and Age Expected to Electrify Asian Medical Device

Market Potential for Tuberculosis Testing Products and Therapeutics Tops $8 Billion

Promising New Drug and Other Trends To Double Smoking Cessation and Addiction Treatments Market by 2010

With Promise of Personalized Medicine, World Molecular Imaging Market Set to Reach $4.75 Billion in 2010

At $42 Billion by 2011, Immunological and BioTherapy Cancer Treatments Near 50% of Market

World Antiviral Market Primed to Reach $24.9 Billion by 2011

Faltering Antibiotics Market to Recover and Surpass $25 Billion by 2010

As Transdermal Drug Delivery Gains Acceptance, Market Shoots to $7.9 Billion

Popularity of LASIK Helping to Drive World Refractive Vision Correction Market to $4.5 Billion by 2009

Total Pulmonary Drug Delivery Market Expected to Top $34 Billion by 2010

Pharmaceutical Profiles to host round table workshop at Bench2Boardroom 2007

---

April 2008

January to March 2008 Biotechnology News

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

---

Site Map - new news site

Site Map - old news site